CD5 (Human) CRISPR/Cas9 Lentivirus (Integrating)

Catalog #
78119
$795 *
Size: 500 µl x 2
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

CD5 is a member of the scavenger receptor cysteine-rich (SRCR) superfamily and is associated with the immune system. This protein is a transmembrane glycoprotein found on the surface of thymocytes and may act as a receptor to regulate T-cell proliferation.

The CD5 CRISPR Lentiviruses are replication incompetent, HIV-based VSV-G  pseudotyped lentiviral particles that are ready to  infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a CRISPR/Cas9 gene driven by an EF1A promoter, along with 5 sgRNA (single guide RNA) targeting human CD5 driven by a U6 promoter (Figures 1 and 2).

The integrating lentivirus integrates randomly into the  cellular genome to express both Cas9 and the sgRNA. Puromycin selection forces high expression levels of both Cas9 and the sgRNA, and can be used with the integrating lentivirus to quickly and easily achieve high knockdown efficiencies in a cell pool. Efficiencies may vary, depending on the cell type and the gene of interest.

Figure 1. Schematic of the Lenti-vector used to generate the CD5 CRISPR/Cas9 Lentivirus

Gene Target: Primer ID: sgRNA Sequence
CD5 CD5-1 CAGCATCTGTGAAGGCACCG
CD5 CD5-2 TTTCCTGAAGCAATGCTCCA
CD5 CD5-3 AAGCGTCAAAAGTCTGCCAG
CD5 CD5-4 GCTGTAGAACTCCACCACGC
CD5 CD5-5 CGTTCCAACTCGAAGTGCCA

Figure 2. List of sgRNA Sequences in the CD5 CRISPR/Cas9 Lentivirus

Synonyms
CD5 molecule, T1, LEU1, CD5 protein, CD5 scavenger receptor cysteine-rich superfamily (SRCR), CD5 lentivirus, CD5 CRISPR
Product Info
Storage and Usage
Citations
Species
Replication Incompetent HIV
Supplied As
Two vials (500 µl x 2) of lentivirus at a titer ≥1 x 106 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Formulation

The lentiviruses were produced from HEK293T cells in medium containing 90% DMEM + 10% FBS.